
Intellectual Property, Antitrust and Cumulative Innovation in the EU and the US
- 330 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
Intellectual Property, Antitrust and Cumulative Innovation in the EU and the US
About this book
For decades, the debate about the tension between IP and antitrust law has revolved around the question to what extent antitrust should accept that IP laws may bar competition in order to stimulate innovation. The rise of IP rights in recent years has highlighted the problem that IP may also impede innovation, if research for new technologies or the marketing of new products requires access to protected prior innovation. How this 'cumulative innovation' is actually accounted for under IP and antitrust laws in the EU and the US, and how it could alternatively be dealt with, are the central questions addressed in this unique study by lawyer and economist Thorsten Käseberg. Taking an integrated view of both IP and antitrust rules – in particular on refusals to deal based on IP – the book assesses policy levers under European and US patent, copyright and trade secrecy laws, such as the bar for and scope of protection as well as research exemptions, compulsory licensing regimes and misuse doctrines. It analyses what the allocation of tasks is and should be between these IP levers and antitrust rules, in particular the law on abuse of dominance (Article 102 TFEU) and monopolisation (Section 2 Sherman Act), while particular attention is paid to the essential facilities doctrine, including pricing methodologies for access to IP. Many recent decisions and judgments are put into a coherent analytical framework, such as IMS Health, AstraZeneca, GlaxoSmithKline (in the EU), Apple (France), Orange Book Standard (Germany), Trinko, Rambus, NYMEX, eBay (US), Microsoft and IBM/T3 (both EU and US). Further topics covered include: IP protection for software, interoperability information and databases; industry-specific tailoring of IP; antitrust innovation market analysis; and the WTO law on the IP/antitrust interface.
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Information
Table of contents
- Cover
- Title
- Copyright
- Acknowledgements
- Contents
- Abbreviations
- Table of Cases
- Table of Legislation
- 1. Introduction
- 2. The Relationship between IP and Antitrust Laws
- 3. The Concepts of Monopolisation and Abuse: What is the Correct Test?
- 4. Refusals to Deal which May Impede Follow-On Innovation
- 5. The Licensing Fee: Determining Liability and the Remedy
- 6. An Essential Facilities Test
- 7. Cumulative Innovation under US IP and Antitrust Laws
- 8. Cumulative Innovation under European IP Laws and EU Competition Law
- 9. Comparison and International Dimension
- 10. Summary
- Bibliography
- Index